IFNA1 and COVID-19: Inherited mutations of genes involved in IFN induction and signaling and circulating auto-antibodies (AABs) that neutralize type I IFNs have been found to predispose infected individuals to severe COVID-19 [7, 8], presumably by contributing to an ineffective immune response with delayed or abolished type I IFN signaling.